Listed

Astonea Labs Ltd IPO

Astonea Labs Ltd is a pharmaceutical company engaged in the development, manufacturing, and marketing of a wide range of medicinal products including tablets, capsules, ointments, and liquids. The company focuses on both domestic and international markets, aiming to provide quality healthcare solutions. With in-house production capabilities and a growing product portfolio, Astonea Labs strives to meet the evolving needs of patients and healthcare providers through innovation and cost-effective treatments.

RHP DRHP Check Allotment Status Anchor Investor link Final Prospectus

Min Investment

₹1,35,000

Lot Size

1,000 Shares

Price Range

₹128.0-135.0

Issue Size (₹ Cr.)

₹37.67

IPO Type

BSE, SME

Key Metrics

Face Value

₹ 10

GMP

₹ 0.0

Subscription

1.79x

EPS

₹ 5.20

P/E Ratio

25.94 x

RoNW

31.83%

ROE

37.86%

Debt to Equity (₹ Cr.)

2.15

Timeline

IPO Opened27/05/2025Tuesday

IPO Closed29/05/2025Thursday

Allotted30/05/2025Friday

Refunded02/06/2025Monday

Listed03/06/2025Tuesday

Strengths

Diverse Product Portfolio – Offers a wide range of pharmaceutical formulations including tablets, capsules, and ointments.
Export-Oriented Growth – Focus on international markets enhances revenue diversification.
Experienced Management Team – Led by professionals with industry expertise.
In-house Manufacturing – Own production facilities help maintain quality and reduce costs.
R&D Focus – Commitment to research and development supports innovation and product expansion.

Weaknesses

Lower market visibility compared to established pharmaceutical brands.
Revenue concentration in a limited range of products.
High regulatory compliance requirements in the pharma industry.
Reliance on external funding for business expansion.
Potential challenges due to limited operational scale.